![Ed Margerrison](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profiel
Ed Margerrison served as President & Chief Executive Officer at ChitogenX, Inc. from 2015 to 2016.
Prior to that, he worked as Vice President-Project Management at Akela Pharma, Inc. Dr. Margerrison holds a doctorate degree from St. George's University of London and an undergraduate degree from The Queen's College (Great Britain).
Eerdere bekende functies van Ed Margerrison
| Bedrijven | Functie | Einde |
|---|---|---|
| CHITOGENX INC. | Algemeen Directeur | 18-10-2016 |
Akela Pharma, Inc.
 Akela Pharma, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceutical formulations and drugs | Corporate Officer/Principal | - |
Opleiding van Ed Margerrison
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
2
Eerstegraads connecties
4
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 4 |
|---|---|
Akela Pharma, Inc.
Akela Pharma, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceutical formulations and drugs | Health Technology |
St. George's University of London
 St. George's University of London Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Queen's College (Great Britain)
 The Queen's College (Great Britain) Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
ChitogenX, Inc.
 ChitogenX, Inc. BiotechnologyHealth Technology Operates as a development stage biotechnology company | Health Technology |
